The Valley Desk

NCT05918861 · Interventional trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

Overall registry status Recruiting

Phase 3

Conditions Acute Coronary Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov